EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease

Hendrik Theis, Nicola Pavese, Irena Rektorová, Thilo van Eimeren

Journal of Parkinson’s Disease · 01.10.2024 · 14 (s2) · S353-S365

DOI: 10.3233/jpd-230385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, online erschienen am 03.02.2024. Verfasst von Hendrik Theis und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, Multimodal Neuroimaging Group, Cologne, G…. Hauptthemen laut MEDLINE: Parkinson Disease, Prodromal Symptoms, Biomarkers. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Assessing imaging biomarker in the prodromal and early phases of Parkinson’s disease (PD) is of great importance to ensure an early and safe diagnosis. In the last decades, imaging modalities advanced and are now able to assess many different aspects of neurodegeneration in PD. MRI sequences can measure iron content or neuromelanin. Apart from SPECT imaging with Ioflupane, more specific PET tracers to assess degeneration of the dopaminergic system are available. Furthermore, metabolic PET patterns can be used to anticipate a phenoconversion from prodromal PD to manifest PD. In this regard, it is worth mentioning that PET imaging of inflammation will gain significance. Molecular imaging of neurotransmitters like serotonin, noradrenaline and acetylcholine shed more light on non-motor symptoms. Outside of the brain, molecular imaging of the heart and gut is used to measure PD-related degeneration of the autonomous nervous system. Moreover, optical coherence tomography can noninvasively detect degeneration of retinal fibers as a potential biomarker in PD. In this review, we describe these state-of-the-art imaging modalities in early and prodromal PD and point out in how far these techniques can and will be used in the future to pave the way towards a biomarker-based staging of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseProdromal SymptomsBiomarkersHumansTomography, Optical CoherencePositron-Emission TomographyNeuroimagingMagnetic Resonance Imaging

Stichwörter der Autor:innen

MRIPETParkinson’s diseasebiomarkerdiagnosisneuroimagingprodromalprogression

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, Multimodal Neuroimaging Group, Cologne, Germany.
  • University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.
  • Aarhus University, Institute of Clinical Medicine, Department of Nuclear Medicine & PET, Aarhus N, Denmark.
  • Newcastle University, Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Masaryk University, Faculty of Medicine and St. Anne's University Hospital, International Clinical Research Center, ICRC, Brno, Czech Republic.
  • Masaryk University, Faculty of Medicine and St. Anne's University Hospital, First Department of Neurology, Brno, Czech Republic.

Zitieren

APA

Theis, H., Pavese, N., Rektorová, I., & van Eimeren, T. (2024). Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease. Journal of Parkinson’s Disease, 14(s2), S353-S365. https://doi.org/10.3233/jpd-230385

Vancouver

Theis H, Pavese N, Rektorová I, van Eimeren T. Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease. Journal of Parkinson’s Disease. 2024;14(s2):S353-S365. doi:10.3233/jpd-230385

BibTeX
@article{Theis2024,
  author = {Theis, Hendrik and Pavese, Nicola and Rektorová, Irena and van Eimeren, Thilo},
  title = {Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease},
  journal = {Journal of Parkinson’s Disease},
  year = {2024},
  volume = {14},
  number = {s2},
  pages = {S353--S365},
  doi = {10.3233/jpd-230385}
}
Kostenlos starten →